Skip Navigation

Cardiovascular Research 2007 75(2):275-282; doi:10.1016/j.cardiores.2007.03.005
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brüne, B.
Right arrow Articles by Zhou, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brüne, B.
Right arrow Articles by Zhou, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

Nitric oxide and superoxide: Interference with hypoxic signaling

Bernhard Brüne* and Jie Zhou

Institute of Biochemistry I, Faculty of Medicine, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany

* Corresponding author. Tel.: +49 69 6301 7423; fax: +49 69 6301 4203. bruene{at}zbc.kgu.de

Sensing and responding to changes in oxygen partial pressure assures that the cellular oxygen supply is tightly controlled in order to balance the risks of oxidative damage vs. oxygen deficiency. The hypoxia inducible factor (HIF) regulatory system is controlled by prolyl hydroxylases (PHDs), the von Hippel Lindau protein (pVHL), and the 26S proteasome and transduces changes in oxygenation to adequate intracellular adaptive responses. A functional HIF response requires stabilization of the {alpha}-subunit, e.g. HIF-1{alpha}, during hypoxia and dimerization with HIF-1β, to drive target gene activation. Intriguingly, high concentrations of nitric oxide (NO) stabilize HIF-1{alpha} and thus mimic a hypoxic response under normoxia. Mechanistically, NO blocks PHD activity and attenuates proline hydroxylation of HIF-1{alpha}. This causes dissociation of pVHL from HIF-1{alpha} and, consequently, HIF-1{alpha} accumulates because proteasomal destruction is impaired. However, during hypoxia low concentrations of NO facilitate destruction of HIF-1{alpha} and thus reverse HIF signaling. Under these conditions, NO impairs respiration and avoids oxygen gradients that limit PHD activity. An additional layer of complexity comprises the interaction of NO with O2–. Signaling qualities attributed to NO are antagonized by compensatory flux rates of O2– and vice versa to adjust levels of HIF-1{alpha} under normoxia and hypoxia. The liaison of NO and hypoxia is versatile and ranges from courting to matrimony and divorce.

KEYWORDS HIF-1; Prolyl hydroxylase; Hypoxia response elements; Mitochondria; Oxygen; Superoxide; Nitric oxide


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Tsuruda, K. Hatakeyama, H. Masuyama, Y. Sekita, T. Imamura, Y. Asada, and K. Kitamura
Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1{alpha} in rat heart
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1274 - H1280.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Leitch, L. T. Jensen, S. D. Bouldin, C. E. Outten, P. J. Hart, and V. C. Culotta
Activation of Cu,Zn-Superoxide Dismutase in the Absence of Oxygen and the Copper Chaperone CCS
J. Biol. Chem., August 14, 2009; 284(33): 21863 - 21871.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. Yzydorczyk, B. Comte, G. Cambonie, J.-C. Lavoie, N. Germain, Y. Ting Shun, J. Wolff, C. Deschepper, R. M. Touyz, M. Lelievre-Pegorier, et al.
Neonatal Oxygen Exposure in Rats Leads to Cardiovascular and Renal Alterations in Adulthood
Hypertension, November 1, 2008; 52(5): 889 - 895.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y.-K. Park, D.-R. Ahn, M. Oh, T. Lee, E. G. Yang, M. Son, and H. Park
Nitric Oxide Donor, ({+/-})-S-Nitroso-N-acetylpenicillamine, Stabilizes Transactive Hypoxia-Inducible Factor-1{alpha} by Inhibiting von Hippel-Lindau Recruitment and Asparagine Hydroxylation
Mol. Pharmacol., July 1, 2008; 74(1): 236 - 245.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. F. Bove, M. Hristova, U. V. Wesley, N. Olson, K. M. Lounsbury, and A. van der Vliet
Inflammatory Levels of Nitric Oxide Inhibit Airway Epithelial Cell Migration by Inhibition of the Kinase ERK1/2 and Activation of Hypoxia-inducible Factor-1{alpha}
J. Biol. Chem., June 27, 2008; 283(26): 17919 - 17928.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Lamas, C. J. Lowenstein, and T. Michel
Nitric oxide signaling comes of age: 20 years and thriving
Cardiovasc Res, July 15, 2007; 75(2): 207 - 209.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.